Patent Box improves large companies’ finances, but is UK innovation getting the same reward?


The most recent official statistics on Patent Box show an increase in the amount of relief claimed, which should be good news for business, innovation and the UK economy. However, the figures also suggest that more can be done by small-medium companies to ensure they are making the most of the incentives.

Read full story

Top Tier ranking in Legal 500 for Patent and Trade Mark teams


Read full story

The role of GB in influencing global IP policy


The recent report by the IPO ‘UK Patent System: Building the evidence base’ discusses the role of the UK in influencing IP policy globally. The UK continues to be a global IP policy key player. However, in light of the approaching impact of Brexit, and what seems to be a fragmenting international landscape in terms of harmonisation, the UK may have to work hard to retain that position.

Read full story

Does the UK Government’s Brexit plans bode well for the UPC?


The UK Government has set out that it is willing to have an implementation period post-Brexit in which it will still be bound by decisions of the CJEU, and will also be bound by new rules in the period immediately post-Brexit. This has positive implications for UK ratification of the UPCA. However, the German government is still wrestling with their own constitutional issues over the UPC, so we are only a little clearer on what might happen.

Read full story

Allergan’s patent shield – The (Native) American dream?


In an unprecedented move, leading global pharmaceutical company Allergan appears to have handed six of its US patents covering its blockbuster dry eye drug Restasis® to the Native American St. Regis Mohawk Tribe in Northern New York. The Tribe has granted exclusive licenses in the patents back to Allergan. The deal will provide the Tribe with $13.75 million up-front and annual royalties of up to $15 million.

Read full story

Changes to EPO Guidelines regarding timing of summons to oral proceedings


The EPO has issued a revised version of its Guidelines for Examination, which will come into effect on 1 November 2017. One key change has been made, which is that Examiners can issue a summons to attend oral proceedings as a first office action after the extended European search report.

Read full story

Unjustified Threats Act to take effect on 1 October 2017


The IP (Unjustified Threats) Act will take effect on 1 October 2017. Amongst other changes, the new law will provide a more consistent framework for dealing with unjustified threats concerning infringement of patents, trademarks and designs.

Read full story

IP Rights: Where Does the Internet Stop? - Gwilym Roberts published in the SCL editorial


Gwilym Roberts gives his view of the recent Canadian case, Google v Equustek, which raises a wide range of jurisdictional issues for those working in IP and tech.

Read full story

Trade mark partners recognised as thought leaders in Who’s Who Legal 2017


The 2017 edition of Who’s Who Legal has recognised Kilburn & Strode as a top tier firm for Thought Leadership, ranking trade mark partners Carrollanne Lindley and Iain Stewart in their 2017 guide.

Read full story

Nick Bassil comments on Indivior losing US Patent dispute in Lawyer Monthly


The drugs group, Indivior, saw £1bn wiped off of its stock value following the loss of a US Patent. Our partner, Nick Bassil, comments to the Lawyer Monthly on the outcome.

Read full story